Trouw: US Lost Measles-Free Status; Dutch Rates Lag
The United States has officially lost its measles-free status, a designation the country had held since 2000.
The regression, reported by Trouw on Thursday shows a sharp decline in public health protections driven by persistent skepticism toward vaccine safety and efficacy.
While the United States grapples with this loss of status, the Netherlands faces its own struggle to maintain herd immunity. Vaccination rates there remain below the 95 percent threshold necessary to prevent outbreaks. Although local flare-ups occurred last year linked to infections contracted abroad, the current situation is described by Trouw as manageable.
Public health officials are simultaneously confronting a rise in HIV diagnoses. In 2025, 500 people in the Netherlands received a diagnosis, a trend Mark Vermeulen, director of Soa Aids Nederland, described as “alarmerend.”
According to the director, this upward trend has been visible for several years.
A primary obstacle is the cost of PrEP, a preventative pill that costs users between 20 and 30 euros per month. This financial barrier persists despite the high cost of treatment, with the healthcare system spending approximately 15,000 euros annually to treat a single individual living with HIV.
Beyond the immediate economic arguments for preventative care, authorities are struggling to counter the spread of medical misinformation.
The report in Trouw suggested a more confrontational approach may be necessary to address those who undermine established science:
“Misschien wordt het toch tijd om het pokkenbriefje van weleer weer van stal te halen of harder op te treden tegen mensen die jarenlang en gedegen onderzoek ongefundeerd verdacht maken,” the report said.